Skip to content

CARDIO 2000

Active
Private limited companyfounded 199828 yrs activeMissionarissenlaan 31, 1070 Anderlecht, BelgiumKBO/BCE: BE 0463.648.320
Summary

CARDIO 2000 has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €937,926 and a net result of €62,385. Equity is growing by ~11.5% per year across the filed fiscal years. Its solvency ranks better than 87% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

What they do
Specialist medical practice
NACE 86220NACE 85120
4 sites
How big
€1.0mtotal assets 2025
Staff
1 FTE
Equity
€937,926
Profit
€62,385
Turnover not published (abridged schema)
Financially healthy?
93 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Who decides
Accounts 43 d early0 of 3 deeds read
Why 93- Liquidity: current ratio 20.97, cash €20,952+ Sector Human health activities (NACE 86)+ Size: total assets €1.0m+ Equity €937,926 (92.7% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Better than 44% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 100=
equity 92.7% of total assets
Liquidity 53=
short-term debt 4.3% · cash 2.1%
Profitability 76-1
return on assets 6.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,628 companies)
  • Sector Human health activities (NACE 86) lowers the probability
  • Liquidity: current ratio 20.97, cash €20,952 raises the probability
  • Size: total assets €1.0m lowers the probability for this profile
  • Equity €937,926 (92.7% of total assets) lowers the probability
Credit up to €85,000 at 30 days acceptable
Liquidity ample (current ratio 20.97 against 18.93 in 2024; short-term debt: 4.3% and cash: 2.1% of total assets), and 7.3% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 82%, liquidity 26%, profitability 21%, growth against the median 47%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
raises risk · Liquidity: current ratio 20.97, cash €20,952
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Size: total assets €1.0m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Equity €937,926 (92.7% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-12-2025, 43 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
43 d early
2024
46 d early
2023
44 d early
2022
43 d early
2021
26 d early
2020
2 d early
2019
25 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 19 December (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close02-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Weakest financial yearnet €62,385 ▼0.2%
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: Among the best 8% on equitysector median €129,633 · 18,233 companies €937,926 View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €62,385 7 years View

By topic

Financials

Fiscal year
2025
Total assets
€1.0m
Profit
€62,385
Solvency
92.7%
Total assets▲ 8.0%
Net result
20192025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 31-01-2027
  1. 19-12-2025Annual accounts filed
  2. 30-06-2025Weakest financial year
  3. 16-12-2024Annual accounts filed
Go to Timeline

Company details

Sites
4
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
25-06-1998
Year ends
30-06
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.